Back to top
more

PRA Health Sciences, Inc. (PRAH)

(Delayed Data from NSDQ)

$93.38 USD

93.38
1,010,066

+1.38 (1.50%)

Updated May 3, 2019 04:00 PM ET

After-Market: $93.43 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks News

PRA Health Sciences (PRAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Add PRA Health to Your Portfolio Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry.

PRA Health Simplifies Treatment Decisions With Metys Launch

PRA Health (PRAH) expects to enhance position and capabilities in the data and analytics field with the new tool, while simplifying treatment decisions.

PRA Health (PRAH) Q2 Earnings Beat, EPS Guidance Narrowed

PRA Health (PRAH) slashes 2019 revenue guidance; direct costs surge in second quarter.

PRA Health Sciences (PRAH) Beats Q2 Earnings Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 1.67% and -0.11%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Healthcare Stock Q2 Earnings Due on Jul 31: HUM, AMED & More

Healthcare stocks like HUM, AMED, CRL, TDOC and PRAH are likely to benefit from higher membership and revenues in the second quarter.

PRA Health Sciences (PRAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to PRA Health (PRAH) Stock Now

PRA Health (PRAH) is gaining steadily from expansion in international markets, solid 2019 outlook and growing CRO industry. However, tough capital spending environment remains a woe.

PRA Health Sciences (PRAH) Down 5.1% Since Last Earnings Report: Can It Rebound?

PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PRA Health (PRAH) Q1 Earnings Beat Estimates, Revenues Miss

PRA Health's (PRAH) Q1 earnings reflect top-line growth, favorable segmental performance and margin expansion.

PRA Health Sciences (PRAH) Surpasses Q1 Earnings Estimates

PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 3.77% and -1.49%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

PRA Health Sciences (PRAH) Reports Next Week: Wall Street Expects Earnings Growth

PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Top Ranked Growth Stocks to Buy for April 24th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 24th.

Top Ranked Growth Stocks to Buy for April 22nd

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 12th.

Top Ranked Growth Stocks to Buy for April 18th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 18th

Top Ranked Growth Stocks to Buy for April 12th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, April 12th.

PRAH vs. HQY: Which Stock Is the Better Value Option?

PRAH vs. HQY: Which Stock Is the Better Value Option?

Top Ranked Growth Stocks to Buy for April 4th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 4th

Top Ranked Growth Stocks to Buy for April 2nd

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, April 2nd

Looking for a Growth Stock? 3 Reasons Why PRA Health Sciences (PRAH) is a Solid Choice

PRA Health Sciences (PRAH) could produce exceptional returns because of its solid growth attributes.

PRA Health Sciences (PRAH) Up 1.2% Since Last Earnings Report: Can It Continue?

PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teladoc to Acquire MedecinDirect, Expand Overseas Business

Teladoc's (TDOC) acquisition of MedecinDirect will aid it in enhancing presence in expanding virtual care market in France.

PRAH vs. HQY: Which Stock Should Value Investors Buy Now?

PRAH vs. HQY: Which Stock Is the Better Value Option?

3 Reasons Growth Investors Will Love PRA Health Sciences (PRAH)

PRA Health Sciences (PRAH) could produce exceptional returns because of its solid growth attributes.

Urmimala Biswas headshot

Encouraging Near-Term Outlook for Medical Services Industry

With growing importance of effective healthcare management, the medical service industry is becoming an integral part of the modern healthcare mechanism.